NAUT

Nautilus Biotechnolgy, Inc. Common Stock
Data: 2026-07-02
$1.73
Price
-5.98%
Change
$4.31
52W High
$0.62
52W Low

Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.

Quick Stats
Jul 02, 2026

56.6

AI Score

HOLD

1.02

Volume Ratio

Jul 30, 2026

Next Earnings

15

+ve Days (30d)

13

-ve Days (30d)

NAUT Stock Summary

Last updated Jul 02, 2026

NAUT is currently trading at $1.73, positioned below its 200-day moving average of $2.15, suggesting bearish momentum. The stock has a 52-week range of $0.62 to $4.3101.

Technical Analysis: The 50-day moving average stands at $2.48, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 28.133, suggesting the stock is oversold and potentially undervalued.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.374, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates NAUT at 56.6/100 with a HOLD recommendation.

NAUT (Nautilus Biotechnolgy, Inc. Common Stock) Indicators

Last updated Jul 02, 2026

Indicator Value
RSI(14) 28.133
CMF (20) -0.374
ROC (10) -20.642
ADX (14) 32.014
Indicator Value
MACD (12,26,9) -0.198
AROONOSC (14) -35.714
WILLAMS %R (14) -94.703
MFI (14) 25.373
NAUT Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

NAUT Price vs Max Options Open Interest
NAUT Max Change In Options Open Interest

NAUT Options - Sort by Max open Interest (near term)

4th July 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

NAUT Daily Out of Money Options - Sort by Max open Interest (near term)

4th July 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

NAUT Daily In the Money Options - Sort by Max open Interest (near term)

4th July 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

NAUT Most Active Options by Volume(near term)

4th July 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Nautilus Biotechnolgy, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

NAUT Moving Averages Analysis

NAUT (Nautilus Biotechnolgy, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Jul 02, 2026

Days MA
10 2.08
20 2.2
30 2.32
50 2.48
100 2.66
200 2.15

NAUT Fundamental Analysis

P/E (Forward) 0
P/E (Trailing) --
Market Cap ($) 233.8 million
Earnings/Share ($) -0.46
Net Proft Margin (%) 0
Dividend/Share ($) --
EPS Estimate Current Year ($) -0.515
EPS Estimate Next Year ($) -0.52
WallStreet Target Price ($) 4
Most Recent Quarter